RxDoctor Payments Data

Tammy Aftanas

Family · Weirton, WVNPI 1588069561

Payments from drug & device makers

$2,305in general payments, 2019–2025

Across 78 payments — averaging $29.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$620
  • AbbVie$303
  • Johnson & Johnson$265
  • Xeris Pharmaceuticals, Inc.$229
  • GSK$207
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$130
  • plus $551 from 15 others

What the payments were for

  • Food & beverage$2,296100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,305 in reported general payments places this provider in the 80th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide157$146,334
JanuviaSitagliptin Phosphate49$32,593
EliquisApixaban46$31,814
JardianceEmpagliflozin30$24,119
FarxigaDapagliflozin Propanediol37$19,749
XareltoRivaroxaban23$17,726
TrulicityDulaglutide12$11,076
Breo ElliptaFluticasone/Vilanterol19$10,838
TradjentaLinagliptin16$10,083
SymbicortBudesonide/Formoterol Fumarate30$9,360
Tresiba Flextouch U-200Insulin Degludec12$7,698
Albuterol Sulfate HfaAlbuterol Sulfate160$4,498
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$3,788
Theophylline ErTheophylline Anhydrous36$2,597
Atorvastatin Calcium509$2,337

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$620$146,334157 claims
MerckJanuvia$58$32,59349 claims
PfizerEliquis$95$31,81446 claims
AstraZenecaFarxiga, Symbicort$28$29,11067 claims
Johnson & JohnsonXarelto$265$17,72623 claims
GSKBreo Ellipta, Shingrix$207$12,98830 claims
Lilly USA, LLCTrulicity$90$11,07612 claims
AbbVieArmour Thyroid$303$88212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,507 family providers in West Virginia.

Other family in Weirton

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →